Sort
39,280 grants matching “leukemia”
Abnormalities/Signal Transduction/Hematopoietic Disease
$1,603,814Dana-Farber Cancer Institute · P01 · FY2002 · DK
Flow Cytometric Analysis of Benign and Malignant Tumors
$1,603,346Maryalice Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA
Targeted Therapy of B-cell Malignancies
$1,603,282David M Goldenberg · Ctr For Molecular Medicine/Immunology · P01 · FY2007 · CA
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,602,982Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
How the 3D architecture of the brain shapes cancer cell fate decisions
$1,602,000Mariella Gruber Filbin · Dana-Farber Cancer Inst · DP2 · FY2021 · NS
Delaware/Christiana Care community Oncology Research Program
$1,600,001Gregory A Masters · Christiana Care Health Services, Inc. · UG1 · FY2016 · CA
MOLECULAR GENETICS OF FANCONI ANEMIA
$1,598,800Oregon Health And Science University · P01 · FY2000 · HL
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,596,896Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,596,329Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2022 · CA
Mouse Models for Understanding Host Responses to Intracellular Pathogens
$1,595,854Ellen A Robey · University Of California Berkeley · P01 · FY2009 · AI
Alliance for Clinical Trials in Oncology Operations Center
$1,595,651Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2016 · CA
Protein Structure
$1,593,257Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,592,921Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
NHGRI/DIR Technology Transfer Program
$1,590,131Daniel Kastner · National Human Genome Research Institute · ZIK · FY2011 · HG
ONCOGENE DEREGULATION/TUMOR SUPPRESSOR GENE LOSS IN CLL
$1,589,968Thomas Jefferson University · P01 · FY2003 · CA
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,588,137Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Metabolic regulation of T cell effector function and anti-tumor immunotherapy
$1,586,326Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
$1,585,639Daniel G Tenen · Beth Israel Deaconess Medical Center · P01 · FY2006 · CA
Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort
$1,584,592Garnet L. Anderson · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Improving Retroviral Vectors for Gene Delivery
$1,584,584University Of Southern California · P01 · FY2003 · CA
Genetic susceptibility to unrelated donor stem cell transplant-related mortality
$1,584,230Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2010 · HL
INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
$1,583,949Daniel G Tenen · Beth Israel Deaconess Medical Center · P01 · FY2007 · CA
Flow Cytometric Analysis of Benign and Malignant Tumors
$1,583,756Maryalice Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIC · FY2013 · CA
Therapeutic Opportunities for Pediatric Astrocytoma
$1,583,141Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2015 · CA
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
$1,581,533Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2019 · CA